TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Moberg Pharma AB
Closing information (x1000 EUR)
| Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Turnover |
19
|
0
|
5,030 |
| Financial expenses |
6
|
23
|
259 |
| Earnings before taxes |
-1,753
|
-1,953
|
1,338 |
| EBITDA |
-1,586
|
-1,677
|
1,972 |
| Total assets |
50,720
|
44,089
|
47,878 |
| Current assets |
11,481
|
10,233
|
16,619 |
| Current liabilities |
2,407
|
1,519
|
7,988 |
| Equity capital |
47,948
|
42,442
|
38,642 |
| - share capital |
883
|
431
|
181 |
| Employees (average) |
8
|
8
|
11 |
Financial ratios
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Solvency |
94.5%
|
96.3%
|
80.7% |
| Turnover per employee |
2
|
0
|
457 |
| Profit as a percentage of turnover | -9226.3% | 26.6% | |
| Return on assets (ROA) |
-3.4%
|
-4.4%
|
3.3% |
| Current ratio |
477.0%
|
673.7%
|
208.0% |
| Return on equity (ROE) |
-3.7%
|
-4.6%
|
3.5% |
| Change turnover |
19
|
-4,937
|
3,480 |
| Change turnover % |
-100%
|
225% | |
| Chg. No. of employees |
0
|
-3
|
-16 |
| Chg. No. of employees % |
0%
|
-27%
|
-59% |
Total value of public sale
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.